SCHEMBL13428008

SCHEMBL13428008

c1ccc(-c2c3ccc(-n4c5ccccc5c5ccccc54)cc3c(-c3ccc4ccccc4c3)c3ccc(-n4c5ccccc5c5ccccc54)cc23)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
KDM4E B2RXH2 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 2/20 0.41
PKM P14618 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
KLF5 Q13887 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MCL1 Q07820 1/20 0.41
DCTPP1 Q9H773 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428283 0.89 KDM4E (0.42) KDM4ETUBB4ATUBBTUBA3CTUBA1B
SCHEMBL11910843 0.89 KDM4E (0.42) KDM4ETUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13319701 0.89 KDM4E (0.42) KDM4ETUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13319702 0.87 KDM4E (0.43) KDM4ELMNAPKMSMN1; SMN2ALDH1A1
SCHEMBL13428016 0.87 TUBB4A (0.35) MAPTKDM4ENPSR1LMNAPKM
SCHEMBL13319706 0.86 DHODH (0.39) MAPTKDM4ENPSR1LMNAMCL1
SCHEMBL12571848 0.86 KDM4E (0.40) KDM4ETUBB4ATUBBTUBA3CTUBA1B
SCHEMBL12769969 0.86 LMNA (0.40) MAPTKDM4ENPSR1LMNAPKM
SCHEMBL13428286 0.85 KDM4E (0.42) KDM4ESMN1; SMN2ALDH1A1TP53HSD17B10
SCHEMBL13427960 0.85 KDM4E (0.42) KDM4ESMN1; SMN2ALDH1A1TP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A MAPT 3713/4885KDM4E 4138/4885NPSR1 1251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.